SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021749
Filing Date
2020-02-14
Accepted
2020-02-14 16:14:31
Documents
1
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm205617d1_sc13ga.htm SC 13G/A 96372
  Complete submission text file 0001104659-20-021749.txt   98108
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 20619949
SIC: 2834 Pharmaceutical Preparations